Search results for: 'China Cell and Gene Therapy Industry Development White Pape'

23 Oct 2020  |  Global  |  Market Research

Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026

Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities

Infographics

×

The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...

The global space industry has been expanding with the entry of new participants and non-space companies that are extending their roles to cater to both the upstream and the downstream segments. The upstream segment is expanding exponentially and is seeing successful launches by low earth orbit (LEO) satellite constellation operators as well as plan...

The homes and buildings industry recorded a robust 8.6% growth in 2022, driven by demand for facility management services, smart home devices, customer experience platforms, and construction management solutions. Increasing adoption of internet of things (IoT) and artificial intelligence (AI)-driven smart building solutions also contributed to the ...

Across various industrial sectors, digitalization has rapidly developed, utilizing several existing and emerging digital technologies, including AI, Big Data analytics (BDA), IoT, machine learning (ML), natural language processing (NLP), robotics, and automation. While the chemicals industry was relatively slow to adopt these technologies, the tran...

The global energy industry is going through an unprecedented transition period, and this change is bringing exciting new growth opportunities to the oil and gas (O&G) sector. However, the shift to a net-zero future for carbon emissions means many companies are also facing pricing, energy security, and industry disruption struggles. The energy indus...

03 Oct 2022  |  Global  |  Technology Research

No Code: The Future of Software Development Process

No-code Platforms Will Disrupt the Way Enterprises Develop Their Applications.

Infographics

×

As enterprises emerge from the COVID-19 pandemic, many are still struggling to completely resume operations, such as streamlining workflows, improving employee productivity, and enhancing customer experience, in an operating environment that is vastly different from what it was 2 years ago. Enterprises’ teams are more geographically dispersed than ...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

The industrial landscape is undergoing a radical transformation. The Digital Industrial Accelerators Program aims to harness the power of the latest innovations in the commercial world and apply them to the manufacturing sector. These innovations include • The metaverse: a virtual environment where people can interact, create, and share experie...

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...